glp-1 supply chain news Agonists Market Report 2025-2033, By Product, Molecule, and Geo Prescription Drug Freight Fraud, June

The Effect of Glucagon-like Peptide 1 and Glucagon-like Peptide 1 Receptor Agonists on Energy Expenditure: A Systematic Review and Meta-Analysis

Turton MD, OShea D, Gunn I, et al

The swallowing reflex triggers earlier

Building on the success of tirzepatidethe first approved dual GLP-1/GIP co-agonistother dual agonists, including those targeting both GLP-1 and GCG receptors, are in an advanced stage of development

accepted April 23, 2026

People who stayed on their GLP-1 medication continuously had an 82 percent lower risk of cardiovascular events like heart attack, stroke, or death during the three-year study period than those who took a sulfonylurea